DWTX Chairman and CEO Greg Duncan stated, “We appreciate the consideration Nasdaq has shown Dogwood Therapeutics, Inc.” He continued, “The Company has a strong cash position of $17.5 million as of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback